Delve into our extensive collection of clinically published studies showcasing real-world evidence.
Viz™ LVO
Background Emergent large vessel occlusion (ELVO) acute ischemic stroke is a time-sensitive disease. Objective To describe our experience with artificial...
Aug 20, 2021
Viz™ LVO
Background Randomized controlled trials have demonstrated the importance of time to endovascular therapy (EVT) in clinical outcomes in large vessel...
Apr 13, 2021
Viz™ LVO
Background Randomized controlled trials have demonstrated the importance of time to endovascular therapy (EVT) on clinical outcomes in large vessel...
Mar 11, 2021
Viz™ LVO
Background Viz.ai artificial intelligence (AI) software utilizes AI powered large vessel occlusion (LVO) detection technology which automatically identifies suspected LVO...
Mar 11, 2021
Viz™ LVO
Background Artificial intelligence algorithms have the potential to become an important diagnostic tool to optimize stroke workflow. Viz LVO is...
Feb 09, 2021
Viz™ LVO
Background Recently approved artificial intelligence (AI) software utilizes AI powered large vessel occlusion (LVO) detection technology which automatically identifies suspected...
Aug 26, 2020
Viz™ LVO
Background Large vessel occlusion (LVO) acute ischemic stroke is a time sensitive disease process. Technology that could shorten the time...
Aug 04, 2020
Viz™ LVO
Background Prompt and accurate identification of Large Vessel Occlusion (LVO) for Acute Ischemic Stroke (AIS) by CTA is essential for...
Jan 30, 2019
